United Therapeutics Corp (UTHR): Share Repurchases
$1.00B
Year ended 2025-12-31
$2.50B
Trailing 12 months to 2026-06-30
+9.7%
10-year compound annual growth
| Period ended | Share Repurchases | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.00B | 0.0% | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | $1.00B | n/a | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | $0 | n/a | 2026-02-25, From 2023-01-01 |
| 2022-12-31 | $0 | n/a | 2025-02-26, From 2022-01-01 |
| No annual figure between 2017-12-31 and 2022-12-31. | |||
| 2017-12-31 | $250.00M | -50.0% | 2020-02-26, From 2017-01-01 |
| 2016-12-31 | $500.00M | +26.7% | 2019-02-27, From 2016-01-01 |
| 2015-12-31 | $394.50M | -18.3% | 2018-02-21, From 2015-01-01 |
| 2014-12-31 | $483.10M | n/m | 2017-02-22, From 2014-01-01 |
| 2013-12-31 | $42.44M | -77.4% | 2016-02-25, From 2013-01-01 |
| 2012-12-31 | $188.00M | -11.3% | 2015-02-24, From 2012-01-01 |
| 2011-12-31 | $212.00M | n/a | 2014-02-25, From 2011-01-01 |
Share Repurchases at similar companies
| Company | Year ended | Share Repurchases | Change YoY |
|---|---|---|---|
| United Therapeutics Corp (UTHR) | 2025-12-31 | $1.00B | 0.0% |
| Royalty Pharma plc (RPRX) | 2025-12-31 | $1.23B | +434.5% |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $125.02M | -59.9% |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | $25.01M | n/a |
| Alkermes plc. (ALKS) | 2024-12-31 | $200.28M | n/a |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | $11.00M | -93.6% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $156.28M | +203.4% |
| Zoetis Inc. (ZTS) | 2025-12-31 | $3.23B | +74.1% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $12.21M | +11.4% |
Compare UTHR, RPRX, JAZZ, SRPT side by side · Screen every company in Pharmaceutical Preparations ↗